857134P
Avanti
18:1 Hemi BMP (S,R)
sn-(3-oleoyl-2-hydroxy)-glycerol-1-phospho-sn-3′-(1′,2′-dioleoyl)-glycerol (ammonium salt), powder
Synonym(s):
110734
Sign Into View Organizational & Contract Pricing
All Photos(2)
About This Item
Empirical Formula (Hill Notation):
C60H114NO11P
CAS Number:
Molecular Weight:
1056.52
UNSPSC Code:
51191904
NACRES:
NA.25
Recommended Products
![18:1 BDP (S,S) sn-[2,3-dioleoyl]-glycerol-1-phospho-sn-1′-[2′,3′-dioleoyl]-glycerol (ammonium salt), powder](/deepweb/assets/sigmaaldrich/product/structures/968/508/ef30cef0-7343-47f1-8394-69c4cd0769d0/640/ef30cef0-7343-47f1-8394-69c4cd0769d0.png)
Assay
>99% (TLC)
form
powder
packaging
pkg of 1 × 5 mg (857134P-5mg)
manufacturer/tradename
Avanti Research™ - A Croda Brand 857134P
lipid type
phospholipids
cardiolipins
shipped in
dry ice
storage temp.
−20°C
SMILES string
[H][C@@](COP(OC[C@@]([H])(O)COC(CCCCCCC/C=C\CCCCCCCC)=O)([O-])=O)(OC(CCCCCCC/C=C\CCCCCCCC)=O)COC(CCCCCCC/C=C\CCCCCCCC)=O.[NH4+]
General description
Hemi-bis(monoacylglycero)phosphate (hemi-BMP) is an anionic lipid, comprising a glycerophosphoglycerol backbone in which three fatty acyl chains are esterified to the glycerol hydroxyls.
Application
18:1 Hemi BMP (S,R) may be used in the preparation of selective organ targeting (SORT) lipid nanoparticles (LNPs) for the selective mRNA delivery to the spleen.
Packaging
5 mL Clear Glass Sealed Ampule (857134P-5mg)
Legal Information
Avanti Research is a trademark of Avanti Polar Lipids, LLC
Storage Class Code
11 - Combustible Solids
WGK
WGK 3
Certificates of Analysis (COA)
Search for Certificates of Analysis (COA) by entering the products Lot/Batch Number. Lot and Batch Numbers can be found on a product’s label following the words ‘Lot’ or ‘Batch’.
Already Own This Product?
Find documentation for the products that you have recently purchased in the Document Library.
Qiang Cheng et al.
Nature nanotechnology, 15(4), 313-320 (2020-04-07)
CRISPR-Cas gene editing and messenger RNA-based protein replacement therapy hold tremendous potential to effectively treat disease-causing mutations with diverse cellular origin. However, it is currently impossible to rationally design nanoparticles that selectively target specific tissues. Here, we report a strategy
Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.
Contact Technical Service